“Quat-Chem’s broad line of products, chemical manufacturing facilities, personnel and existing business made the company an attractive acquisition opportunity for us. We’re very pleased to announce that Quat-Chem has joined Neogen,” says Dr. Jason Lilly, Neogen’s vice president of corporate development. “This acquisition is another step, along with our May 2016 acquisition of Preserve International, towards Neogen becoming a global biosecurity product leader.”

Quat-Chem is headquartered in an accredited, recently expanded facility in Rochdale, England, near Manchester, and its operations will be managed by Neogen’s Scotland-based Neogen Europe subsidiary. Quat-Chem has a strong history in nitrogen-based chemistry, as an internationally recognized supplier of the widely used biocidal active benzalkonium chloride, as well as amine oxide, a key surfactant.

“Adding Quat-Chem’s biosecurity products and capabilities will complement what we can offer to our customers,” says Dr. Stephen Holmes, managing director of Neogen Europe. “Our new operation in Rochdale will work in close cooperation with our nearby Lab M location.”

Neogen’s acquisition of Quat-Chem is the latest in its strategy of expanding the company’s biosecurity business, which began in 2003 with its acquisition of rodenticides, cleaners and disinfectants from ConAgra. The expansion continued with Neogen’s 2008 acquisition of DuPont’s biosecurity product line, the 2014 acquisition of Chem-Tech, and 2016 acquisitions of Preserve International and Virbac’s rodenticides.

Terms of the current agreement were not disclosed.